Roche Dealmakers On The Immunology Technology They're Shopping For

 
• By Sue Sutter

Business development execs Patrick Schleck and Michael Crowley talk to Scrip about the company’s recent deals with Parvus, Jecure and Microbiotica in the inflammatory and autoimmune disease space.

Business handshake and business people on deal concept. vintage tone. - Image
Roche's dealmakers are looking for novel biologic approaches and technologies in the immunology space. • Source: Shutterstock

More from Deals

More from Business